Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO1992010477) MEDICAMENTS
Latest bibliographic data on file with the International Bureau

Pub. No.: WO/1992/010477 International Application No.: PCT/EP1991/002362
Publication Date: 25.06.1992 International Filing Date: 10.12.1991
Chapter 2 Demand Filed: 08.07.1992
IPC:
C07D 209/16 (2006.01)
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
D
HETEROCYCLIC COMPOUNDS
209
Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
02
condensed with one carbocyclic ring
04
Indoles; Hydrogenated indoles
10
with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
14
Radicals substituted by nitrogen atoms, not forming part of a nitro radical
16
Tryptamines
Applicants:
GLAXO GROUP LIMITED [GB/GB]; Glaxo House Berkeley Avenue Greenford Middlesex UB6 0NN, GB (AllExceptUS)
CRAIG, Joanne [GB/GB]; GB (UsOnly)
CROOKES, Derek, Leslie [GB/GB]; GB (UsOnly)
SKITTRALL, Stephen, John [GB/GB]; GB (UsOnly)
Inventors:
CRAIG, Joanne; GB
CROOKES, Derek, Leslie; GB
SKITTRALL, Stephen, John; GB
Agent:
KYLE, Diana; Elkington and Fife Prospect House 8 Pembroke Road Sevenoaks Kent TN13 1XR, GB
Priority Data:
9026998.612.12.1990GB
Title (EN) MEDICAMENTS
(FR) MEDICAMENTS
Abstract:
(EN) 3-[2-(dimethylamino)ethyl]-N-methyl-1H-indole-5-methanesulphonamide sulphate salt (2:1) and pharmaceutically acceptable solvates thereof are disclosed. The compound is of use in the preparation of pharmaceutical compositions, particularly for intranasal formulations, for use in the treatment of conditions associated with cephalic pain, in particular migraine.
(FR) Sel de sulfate 3-[2-(diméthylamino)éthyl]-N-méthyl-1H-indole-5-méthanesulfamide, et ses solvates pharmaceutiquement acceptables. Ce composé est utile à la préparation de compositions pharmaceutiques, notamment les formulations utilisables à l'intérieur du nez, destinées au traitement des affections associées à la douleur céphalique, notamment la migraine.
Designated States: AU, BB, BG, BR, CA, CS, FI, HU, JP, KP, KR, LK, MG, MN, NO, PL, RO, SU, US
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, ML, MR, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)
Also published as:
CZPV1993-1140MXPA/a/1991/002501ZA1991/09750ES2069836EP0490689RU02108328
US5554639US5705520JPH06503560CN1128259BH1222CA2098302
DE000069108200PT99757GB2251614KR1002114790000*AU1991090720FR2670487
DK0490689MYPI 91002297